
Mangalore-based Mukka Proteins refiles for IPO with SEBI
Mukka Proteins earlier filed the draft papers for Initial Public Offering (IPO) with the regulator in March 2022
Stay updated with the latest news and articles about SEBI approval.
Mukka Proteins earlier filed the draft papers for Initial Public Offering (IPO) with the regulator in March 2022
BSE Technologies, a 100 per cent subsidiary of BSE, has received authorisation from Securities and Exchange Board of India (SEBI) to act as a KYC KRA agency.
The Indian government has urged the market regulator-SEBI to complete its vetting process in less than three weeks instead of the 75 days it usually requires.
The company had filed its Draft Red Herring Prospectus (DRHP) with the Securities & Exchange Board of India (SEBI) in September last year and is aiming to raise Rs 8,430 crore, including a primary issuance of Rs 7,000 crore.
As of 12: 59 pm, the company was trading at Rs. 16,410.00 on BSE. Bajaj Finance share prices also went up by 4.08% to trade at Rs. 7,028.00.
Following the approval, Bajaj Finserv’s share prices went up by 4% to reach a new high of Rs 15,875 apiece on BSE. With the surge in prices, the company’s market capitalization touched the Rs. 2.5 trillion marks.